- Home
- PLBY vs RLYB Comparison
PLBY vs RLYB Comparison
Compare PLBY & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLBY
- RLYB
- Stock Information
- Founded
- PLBY 1953
- RLYB 2018
- Country
- PLBY United States
- RLYB United States
- Employees
- PLBY N/A
- RLYB N/A
- Industry
- PLBY Recreational Games/Products/Toys
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- PLBY Consumer Discretionary
- RLYB Health Care
- Exchange
- PLBY Nasdaq
- RLYB Nasdaq
- Market Cap
- PLBY 142.4M
- RLYB 45.2M
- IPO Year
- PLBY N/A
- RLYB 2021
- Fundamental
- Price
- PLBY $1.65
- RLYB $0.95
- Analyst Decision
- PLBY Buy
- RLYB Buy
- Analyst Count
- PLBY 2
- RLYB 6
- Target Price
- PLBY $2.35
- RLYB $8.10
- AVG Volume (30 Days)
- PLBY 841.0K
- RLYB 106.4K
- Earning Date
- PLBY 11-12-2024
- RLYB 11-07-2024
- Dividend Yield
- PLBY N/A
- RLYB N/A
- EPS Growth
- PLBY N/A
- RLYB N/A
- EPS
- PLBY N/A
- RLYB N/A
- Revenue
- PLBY $124,761,000.00
- RLYB $598,000.00
- Revenue This Year
- PLBY N/A
- RLYB N/A
- Revenue Next Year
- PLBY N/A
- RLYB N/A
- P/E Ratio
- PLBY N/A
- RLYB N/A
- Revenue Growth
- PLBY 30.09
- RLYB N/A
- 52 Week Low
- PLBY $0.52
- RLYB $0.93
- 52 Week High
- PLBY $1.99
- RLYB $3.46
- Technical
- Relative Strength Index (RSI)
- PLBY 58.94
- RLYB 37.53
- Support Level
- PLBY $1.33
- RLYB $0.93
- Resistance Level
- PLBY $1.99
- RLYB $1.24
- Average True Range (ATR)
- PLBY 0.18
- RLYB 0.08
- MACD
- PLBY -0.00
- RLYB -0.02
- Stochastic Oscillator
- PLBY 50.00
- RLYB 6.45
About PLBY PLBY Group Inc.
PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.